Semb B K, Steen S, Solhaug J H
Scand J Gastroenterol. 1982 Oct;17(7):843-8. doi: 10.3109/00365528209181103.
Continuous intravenous infusion of small doses of vasopressin (0.05 microgram/kg/h) in anaesthetized dogs was effective in reducing gastric mucosal flow, whereas moderate doses (0.2 micrograms/kg/h) induced a substantial flow reduction. Larger doses of vasopressin (2-4 micrograms/kg/h) precipitated massive gastric flow reduction with subsequent hyperaemia, which was not effectively controlled by moderate vasopressin doses. The effect of intraportal infusion of vasopressin on mucosal flow was similar to that of intravenous infusion. Prolonged intravenous infusion of moderate vasopressin doses maintained mucosal flow reduction over extended periods. The implications of the findings are discussed with particular reference to clinical use of vasopressin as a means of controlling bleeding from gastric mucosal lesions in patients.
对麻醉犬持续静脉输注小剂量血管加压素(0.05微克/千克/小时)可有效降低胃黏膜血流量,而中等剂量(0.2微克/千克/小时)则会导致血流量大幅减少。更大剂量的血管加压素(2 - 4微克/千克/小时)会使胃血流量大幅减少,随后出现充血,中等剂量的血管加压素无法有效控制这种情况。门静脉输注血管加压素对黏膜血流量的影响与静脉输注相似。长时间静脉输注中等剂量的血管加压素可使黏膜血流量在较长时间内维持减少状态。本文结合血管加压素在临床上作为控制患者胃黏膜病变出血手段的应用,对这些研究结果的意义进行了讨论。